Literature DB >> 26708507

Macrophages and pancreatic ductal adenocarcinoma.

Aida Habtezion1, Mouad Edderkaoui2, Stephen J Pandol2.   

Abstract

Monocytes and macrophages make up part of the innate immune system and provide one of the first defenses against variety of treats. Macrophages can also modulate the adaptive immune system. Efficient sensing and response to tissue environmental cues highlights the complexity and dynamic nature of macrophages and their plasticity. Macrophages may have divergent roles depending on their polarity and stimulus received. Accumulating evidence demonstrates the critical role played by macrophages in tumor initiation, development, and progression. In this review, we discuss the characteristics of tumor-associated macrophages (TAMs) and their role in pancreatic adenocarcinoma. In addition, we give an overview on recent advances related to the therapeutic implication associated with targeting TAMs in pancreas cancer.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Macrophages; Pancreas cancer; Pancreatic ductal adenocarcinoma; Tumor associated macrophages

Mesh:

Substances:

Year:  2015        PMID: 26708507      PMCID: PMC4912945          DOI: 10.1016/j.canlet.2015.11.049

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  91 in total

1.  Cancer stem cells and EMT in carcinoma.

Authors:  Adrian Biddle; Ian C Mackenzie
Journal:  Cancer Metastasis Rev       Date:  2012-02-03       Impact factor: 9.264

2.  Clinical Analysis and Comprehensive Treatment of Nonfunctional Pancreatic Neuroendocrine Tumor With Liver Metastases: A Retrospective Single-Center Study.

Authors:  Xuefeng Xu; Xu Han; Lingxiao Liu; Yuan Ji; Jianang Li; Wenhui Lou
Journal:  Pancreas       Date:  2015-08       Impact factor: 3.327

3.  Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.

Authors:  Andrea Casazza; Damya Laoui; Mathias Wenes; Sabrina Rizzolio; Nicklas Bassani; Marco Mambretti; Sofie Deschoemaeker; Jo A Van Ginderachter; Luca Tamagnone; Massimiliano Mazzone
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

4.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

Authors:  Vasilena Gocheva; Hao-Wei Wang; Bedrick B Gadea; Tanaya Shree; Karen E Hunter; Alfred L Garfall; Tara Berman; Johanna A Joyce
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

5.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.

Authors:  Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

6.  M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway.

Authors:  Chao-Ying Liu; Juan-Ying Xu; Xiao-Yan Shi; Wei Huang; Ting-Yan Ruan; Ping Xie; Jun-Li Ding
Journal:  Lab Invest       Date:  2013-06-10       Impact factor: 5.662

7.  Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages.

Authors:  P Allavena; M Chieppa; G Bianchi; G Solinas; M Fabbri; G Laskarin; A Mantovani
Journal:  Clin Dev Immunol       Date:  2011-02-09

Review 8.  Preparing the "soil": the premetastatic niche.

Authors:  Rosandra N Kaplan; Shahin Rafii; David Lyden
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

9.  Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs.

Authors:  Geou-Yarh Liou; Heike Döppler; Brian Necela; Murli Krishna; Howard C Crawford; Massimo Raimondo; Peter Storz
Journal:  J Cell Biol       Date:  2013-08-05       Impact factor: 10.539

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  27 in total

1.  Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer.

Authors:  Supriya Srinivasan; Tulasigeri Totiger; Chanjuan Shi; Jason Castellanos; Purushottam Lamichhane; Austin R Dosch; Fanuel Messaggio; Nilesh Kashikar; Kumaraswamy Honnenahally; Yuguang Ban; Nipun B Merchant; Michael VanSaun; Nagaraj S Nagathihalli
Journal:  Cancer Res       Date:  2018-09-19       Impact factor: 12.701

2.  Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers.

Authors:  Erik S Knudsen; Paris Vail; Uthra Balaji; Hoai Ngo; Ihab W Botros; Vladimir Makarov; Nadeem Riaz; Vinod Balachandran; Steven Leach; Debrah M Thompson; Timothy A Chan; Agnieszka K Witkiewicz
Journal:  Clin Cancer Res       Date:  2017-03-27       Impact factor: 12.531

Review 3.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

4.  KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Authors:  Faraz Bishehsari; Lijuan Zhang; Usman Barlass; Nailliw Z Preite; Sanja Turturro; Matthew S Najor; Brandon B Shetuni; Janet P Zayas; Mahboobeh Mahdavinia; Abde M Abukhdeir; Ali Keshavarzian
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

Review 5.  Carcinogenesis of Pancreatic Ductal Adenocarcinoma.

Authors:  Peter Storz; Howard C Crawford
Journal:  Gastroenterology       Date:  2020-03-19       Impact factor: 22.682

6.  NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development.

Authors:  Nivedita M Ratnam; Jennifer M Peterson; Erin E Talbert; Katherine J Ladner; Priyani V Rajasekera; Carl R Schmidt; Mary E Dillhoff; Benjamin J Swanson; Ericka Haverick; Raleigh D Kladney; Terence M Williams; Gustavo W Leone; David J Wang; Denis C Guttridge
Journal:  J Clin Invest       Date:  2017-09-11       Impact factor: 14.808

Review 7.  Tobacco and alcohol as risk factors for pancreatic cancer.

Authors:  Murray Korc; Christie Y Jeon; Mouad Edderkaoui; Stephen J Pandol; Maxim S Petrov
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-09-06       Impact factor: 3.043

Review 8.  Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma.

Authors:  Veethika Pandey; Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2019-05-31       Impact factor: 4.512

Review 9.  Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.

Authors:  Ramiz S Ahmad; Timothy D Eubank; Slawomir Lukomski; Brian A Boone
Journal:  Biomolecules       Date:  2021-06-17

10.  A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer.

Authors:  Tamas A Gonda; Jarwei Fang; Martha Salas; Catherine Do; Emily Hsu; Anna Zhukovskaya; Ariel Siegel; Ryota Takahashi; Zoila A Lopez-Bujanda; Charles G Drake; Gulam A Manji; Timothy C Wang; Kenneth P Olive; Benjamin Tycko
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.